Disclosure statement
Consulting/honoraria/advisory boards: AbbVie, Agios, Amgen, AstraZeneca, CareVive, BMS/Celgene, Daiichi-Sankyo, Flatiron, Helsinn, Heron, Otsuka, Medtronic, Pfizer, Seattle Genetics, Welvie: Speakers bureaus: Agios, AbbVie, and Bristol Myers Squibb/Celgene. Research funding: American Cancer Society, AstraZeneca, BMS, Duke University, NINR/NIH, Jazz Pharmaceuticals, Seattle Genetics. Royalties: UpToDate.